Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

The right cells and signals can potentially lead to scarless wound healing, with a mix of natural and external wound healing controllers possibly being the best way to achieve this.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The article concludes that the global hair trade is exploitative and reflects complex cultural and economic issues.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Alopecia areata is an autoimmune condition causing patchy hair loss, with treatments focusing on immune system regulation and hair regrowth.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

No cure exists for alopecia areata; treatments aim to manage symptoms.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Two siblings both had a rare case of alopecia areata at the same time.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

FFA patients have fewer melanocytes and thinner skin compared to others.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.